The effect of tumor-associated protein RCAS1 gene silencing on blood pressure and urinary protein excretion in pregnant mouse: a pilot study

Am J Obstet Gynecol. 2010 Oct;203(4):364.e6-364.e12. doi: 10.1016/j.ajog.2010.05.015. Epub 2010 Jun 26.

Abstract

Objective: The level of tumor-associated receptor-binding cancer antigen that is expressed on SiSo cells (RCAS1) is decreased significantly in preeclamptic pregnancies. We hypothesized that RCAS1 protein gene silencing might affect blood pressure and proteinuria in pregnant mice.

Study design: On postcoital day 7.5, pregnant imprinting control region mice were subjected to the transfer of small interfering RNA (siRNA) against RCAS1 protein into the uterine cavity with the use of a hemagglutinating virus Japan envelope. Scramble siRNA was used as a negative control. Blood pressure and urine albumin/creatinine measurements were performed. The effect of the transferred siRNA was examined in uterine samples on postcoital day 8.5 with the use of Western blotting and immunohistochemistry analyses.

Results: In the RCAS1 siRNA group, blood pressure significantly raised on postcoital days 9.5, 10.5, 11.5, and 15.5, whereas urine albumin/creatinine ratio was significantly increased on postcoital day 9.5

Conclusion: Our results suggest the importance of RCAS1 protein in the pathophysiologic condition of preeclampsia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Albuminuria*
  • Animals
  • Antigens, Neoplasm / genetics*
  • Blood Pressure*
  • Blotting, Western
  • Creatinine / urine*
  • Female
  • Gene Silencing*
  • Immunohistochemistry
  • Mice
  • Pilot Projects
  • Pre-Eclampsia / genetics
  • Pregnancy
  • Pregnancy Outcome
  • RNA, Small Interfering / genetics
  • Transfection

Substances

  • Antigens, Neoplasm
  • EBAG9 protein, mouse
  • RNA, Small Interfering
  • Creatinine